It maintains profit guidance, though.
Chief Legal and Corporate Affairs Officer signing off.
Here are the results of Portfolio's monthly survey.
This time only 5,000, though.
60,000 shares this time.
That's way more than what analysts expect.
It has been for days.
Pharmafarm is back in business.
For HUF 479 million this time.
Signs license and distribution agreement.
Sertorius buys 63,000 OTP shares this time.
Sertorius Fund aquires more than 43,000 OTP shares.
Women's Healthcare portfolio expanded.
Rating remains unchanged.
Hardly any of them expect a major decline.
The EBITDA and EPS estimates have also been upped.
To HUF 570 per share from HUF 600.
J.P. Morgan also cuts rating.
U.S. FDA rejects application by Allergan.